Physician profile
Peter Thomas Galantich
NPI 1457321515
$2,863.91
in general payments reported to CMS, 2019-2025
12 companies · $269 in 2025
The $269 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $168 · 2021: $64.50 · 2022: $529 · 2023: $665 · 2024: $1,010 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,944.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,742.05 | 2022-2025 | Inspire |
| Intersect Ent, INC. | $297.68 | 2019-2021 | |
| Optinose US, INC. | $259.36 | 2019-2025 | |
| Aerin Medical INC. | $229.29 | 2024 | |
| Davol INC. | $91.05 | 2023 | Arista Ah Flexitip |
| Regeneron Healthcare Solutions, INC. | $70.67 | 2024-2025 | Dupixent |
| Glaxosmithkline, LLC. | $41.55 | 2022-2024 | Nucala |
| Medtronic, INC. | $41.30 | 2023-2024 | Pteye Parathyroid Detection System, Ligasure |
| Karl Storz Endoscopy-America | $37.99 | 2022 | |
| Genzyme Corporation | $19.06 | 2019 | |
| Ambu INC. | $17.68 | 2022 | |
| Merck Sharp & Dohme LLC | $16.23 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Galantich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.